Literature DB >> 11413153

Acute graft-versus-host disease: inflammation run amok?

J H Antin1.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11413153      PMCID: PMC200198          DOI: 10.1172/JCI13259

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.

Authors:  K R Cooke; A Gerbitz; J M Crawford; T Teshima; G R Hill; A Tesolin; D P Rossignol; J L Ferrara
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.

Authors:  H Glucksberg; R Storb; A Fefer; C D Buckner; P E Neiman; R A Clift; K G Lerner; E D Thomas
Journal:  Transplantation       Date:  1974-10       Impact factor: 4.939

3.  Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function.

Authors:  T Kuroiwa; E Kakishita; T Hamano; Y Kataoka; Y Seto; N Iwata; Y Kaneda; K Matsumoto; T Nakamura; T Ueki; J Fujimoto; T Iwasaki
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

4.  Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation.

Authors:  D W Beelen; E Haralambie; H Brandt; G Linzenmeier; K D Müller; K Quabeck; H G Sayer; U Graeven; H K Mahmoud; U W Schaefer
Journal:  Blood       Date:  1992-11-15       Impact factor: 22.113

5.  Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.

Authors:  R Storb; R L Prentice; C D Buckner; R A Clift; F Appelbaum; J Deeg; K Doney; J A Hansen; M Mason; J E Sanders; J Singer; K M Sullivan; R P Witherspoon; E D Thomas
Journal:  N Engl J Med       Date:  1983-02-10       Impact factor: 91.245

  5 in total
  8 in total

Review 1.  Acute graft-versus-host disease: from the bench to the bedside.

Authors:  Gerard Socié; Bruce R Blazar
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

Review 2.  New strategies for prevention and treatment of graft-versus-host disease and for induction of graft-versus-leukemia effects.

Authors:  H Joachim Deeg
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

3.  Ocular manifestations of graft-versus-host disease.

Authors:  Amr Nassar; Khalid F Tabbara; Mahmoud Aljurf
Journal:  Saudi J Ophthalmol       Date:  2013-07

4.  Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients.

Authors:  C Espina; I Jenkins; L Taylor; R Farah; E Cho; J Epworth; K Coleman; J Pinelli; S Mentzer; L Jarrett; T Gooley; P O'Donnell; I B Hirsch; M Bar
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483

5.  Interleukin-7 receptor-alpha gene polymorphisms in bone marrow transplant recipients.

Authors:  Negar Azarpira; Mehdi Dehghani; Mahdokth H Aghdaie; Masumeh Darai
Journal:  Mol Biol Rep       Date:  2009-03-01       Impact factor: 2.316

6.  Circulating Levels of Adipokines Predict the Occurrence of Acute Graft-versus-host Disease.

Authors:  Jin Sook Kim; Da-Bin You; Ji-Young Lim; Sung-Eun Lee; Yoo-Jin Kim; Hee-Je Kim; Nack-Gyun Chung; Chang-Ki Min
Journal:  Immune Netw       Date:  2015-04-23       Impact factor: 6.303

7.  Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model.

Authors:  Radhika Gangaraju; Yanjun Chen; Lindsey Hageman; Jessica Wu; Liton Francisco; Michelle Kung; Daniel J Weisdorf; Stephen J Forman; Mukta Arora; Saro H Armenian; Smita Bhatia
Journal:  Blood Adv       Date:  2021-10-26

8.  Chronic graft-versus-host disease in pancreas after kidney transplant recipients - An unrecognized entity.

Authors:  Prince Singh; Raymund R Razonable; Elizabeth C Lorenz; David J DiCaudo; William R Sukov; Alina G Bridges; Hassan B Alkhateeb; William J Hogan; Nattawat Klomjit; Sorkko Thirunavukkarasu; Hatem Amer; Yogish C Kudva; Hassan Khamash; Mark Stegall; Aleksandra Kukla
Journal:  Am J Transplant       Date:  2020-09-20       Impact factor: 8.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.